Epidemiology of MPN: What Do We Know?

被引:0
|
作者
L. A. Anderson
M. F. McMullin
机构
[1] Queen’s University Belfast,Centre for Public Health
[2] Queen’s University Belfast,Centre for Cancer Research and Cell Biology
来源
Current Hematologic Malignancy Reports | 2014年 / 9卷
关键词
Epidemiology; Myeloproliferative neoplasms; Survival; Body mass index; Diet; Benzene;
D O I
暂无
中图分类号
学科分类号
摘要
The myeloproliferative neoplasms, are characterised by overproduction of myeloid cells. Chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia, myelofibrosis and the very rare disorders chronic neutrophilic leukaemia, chronic eosinophilic leukaemia not otherwise specified and mastocytosis are all included in the group. Incidence and prevalence rates reported in the worldwide literature are presented in this review. Survival data on each condition is described. Information on the aetiology of the disorders is discussed including body mass index, diet, smoking and alcohol, allergies, associated medical conditions, occupation and environmental exposures with focus on recent new studies. The aetiology of the myeloproliferative neoplasms remains unknown, and this review of the current state of knowledge highlights the need for further comprehensive research.
引用
收藏
页码:340 / 349
页数:9
相关论文
共 50 条
  • [41] What Do We Know about Diet and Markers of Cardiovascular Health in Children: A Review
    Saeedi, Pouya
    Shavandi, Amin
    Skidmore, Paula M. L.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (04)
  • [42] What we know and still do not know about tick-borne encephalitis?
    Kriha, M. F.
    Chrdle, A.
    Ruzek, D.
    Chmelik, V
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2021, 70 (03): : 189 - 198
  • [43] Genetic epidemiology of epilepsy or what do we tell families?
    Winawer, MR
    Shinnar, J
    EPILEPSIA, 2005, 46 : 24 - 30
  • [44] Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies
    McKinnell, Zoe
    Karel, Daniel
    Tuerff, Daniel
    Abrahim, Marwa S. H.
    Nassereddine, Samah
    JOURNAL OF HEMATOLOGY, 2022, 11 (06) : 197 - 209
  • [45] Metabolic syndrome - What we know and what we don't know
    Ritz, Eberhard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1619 - 1623
  • [46] Contagious itch: what we know and what we would like to know
    Schut, C.
    Grossman, S.
    Gieler, U.
    Kupfer, J.
    Yosipovitch, G.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2015, 9
  • [47] Pneumonia in Bhutanese children: what we know, and what we need to know
    Jullien, Sophie
    Pradhan, Dinesh
    Bassat, Quique
    PNEUMONIA, 2020, 12 (01)
  • [48] Dietary phosphate: what do we know about its toxicity?
    Jain, Nishank
    Elsayed, Essam F.
    JOURNAL OF NEPHROLOGY, 2013, 26 (05) : 856 - 864
  • [49] BARIATRIC SURGERY IN ADOLESCENTS: WHAT DO WE KNOW SO FAR?
    Beamish, A. J.
    Johansson, S. E.
    Olbers, T.
    SCANDINAVIAN JOURNAL OF SURGERY, 2015, 104 (01) : 24 - 32
  • [50] What Do We Know Now About Autologous Fat Grafting?
    Gal, Shaili
    Xue, Yunfeng
    Pu, Lee L. Q.
    ANNALS OF PLASTIC SURGERY, 2019, 83 : S17 - S20